| Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance D Ge, J Fellay, AJ Thompson, JS Simon, KV Shianna, TJ Urban, ... Nature 461 (7262), 399-401, 2009 | 4517 | 2009 |
| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2109 | 2017 |
| Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised … International Carotid Stenting Study investigators The Lancet 375 (9719), 985-997, 2010 | 1563 | 2010 |
| Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus AJ Thompson, AJ Muir, MS Sulkowski, D Ge, J Fellay, KV Shianna, ... Gastroenterology 139 (1), 120-129. e18, 2010 | 963 | 2010 |
| Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up E Senkus, S Kyriakides, F Penault-Llorca, P Poortmans, A Thompson, ... Annals of oncology 24, vi7-vi23, 2013 | 709 | 2013 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 561 | 2014 |
| ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C J Fellay, AJ Thompson, D Ge, CE Gumbs, TJ Urban, KV Shianna, LD Little, ... Nature 464 (7287), 405-408, 2010 | 552 | 2010 |
| Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers AJV Thompson, T Nguyen, D Iser, A Ayres, K Jackson, M Littlejohn, ... Hepatology 51 (6), 1933-1944, 2010 | 538 | 2010 |
| Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia T Nguyen, AJV Thompson, S Bowden, C Croagh, S Bell, PV Desmond, ... Journal of hepatology 52 (4), 508-513, 2010 | 507 | 2010 |
| IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C TJ Urban, AJ Thompson, SS Bradrick, J Fellay, D Schuppan, KD Cronin, ... Hepatology 52 (6), 1888-1896, 2010 | 464 | 2010 |
| Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin JJ McCarthy, JH Li, A Thompson, S Suchindran, XQ Lao, K Patel, ... Gastroenterology 138 (7), 2307-2314, 2010 | 454 | 2010 |
| An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response A Mangia, AJ Thompson, R Santoro, V Piazzolla, HL Tillmann, K Patel, ... Gastroenterology 139 (3), 821-827. e1, 2010 | 419 | 2010 |
| Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines S Dumbreck, A Flynn, M Nairn, M Wilson, S Treweek, SW Mercer, ... bmj 350, 2015 | 412 | 2015 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 411 | 2014 |
| Fatty acid membrane assembly on coacervate microdroplets as a step towards a hybrid protocell model TY Dora Tang, C Rohaida Che Hak, AJ Thompson, MK Kuimova, ... Nature chemistry 6 (6), 527-533, 2014 | 355 | 2014 |
| Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: a randomized phase III study (ALLY‐3+) V Leroy, P Angus, JP Bronowicki, GJ Dore, C Hezode, S Pianko, S Pol, ... Hepatology 63 (5), 1430-1441, 2016 | 342 | 2016 |
| Efficacy of 8 weeks of sofosbuvir, velpatasvir, and voxilaprevir in patients with chronic HCV infection: 2 phase 3 randomized trials IM Jacobson, E Lawitz, EJ Gane, BE Willems, PJ Ruane, RG Nahass, ... Gastroenterology 153 (1), 113-122, 2017 | 297 | 2017 |
| Strategies to manage hepatitis C virus (HCV) disease burden H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ... Journal of viral hepatitis 21, 60-89, 2014 | 274 | 2014 |
| Interleukin‐28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus … MR Charlton, A Thompson, BJ Veldt, K Watt, H Tillmann, JJ Poterucha, ... Hepatology 53 (1), 317-324, 2011 | 255 | 2011 |
| Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction AJ Thompson, J Fellay, K Patel, HL Tillmann, S Naggie, D Ge, TJ Urban, ... Gastroenterology 139 (4), 1181-1189. e2, 2010 | 226 | 2010 |
